The antimicrobials market is projected to expand from USD 117.6 billion in 2026 to USD 197.0 billion by 2036, registering a CAGR of 5.3%. By type, antibacterial agents will dominate global demand with a 45.3% share, while synthetic antimicrobials will remain the largest origin segment accounting for 51.7% share.